Remove 2019 Remove Complication Remove Families Remove Management
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

mg or placebo in 2019. 15 Also, a systematic review (2019) of 50,452 diabetes patients did not show a statistically significant increase of the overall cancer risk (OR 1.04; 95% CI: 0.94 Der Beitrag Key Facts GPs Should Know About GLP-1 Analogs erschien zuerst auf Family Medicine Initiative. semaglutide 1.0

Diabetes 130
article thumbnail

Overtreatment of prostate cancer in the active surveillance era

Common Sense Family Doctor

Concerns about overdiagnosis of clinically insignificant prostate cancer through prostate specific antigen (PSA) screening motivated the 2018 American Academy of Family Physicians’ (AAFP) recommendation against routine screening for prostate cancer. in 2019, with 78% receiving radiation therapy and 22% undergoing surgery.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

An Arm and a Leg: The Prescription Drug Playbook, Part I

Physician's Weekly

Dozens of listeners responded with their stories, including Bob, who is being identified only by his first name to guard his family’s privacy and whose daughter has epilepsy. Back in February, we asked you, our listeners, to tell us how you’ve managed when your prescriptions got really expensive.

article thumbnail

Private Equity Gobbling Up Hospices plus Hospice and Dementia: Melissa Aldridge, Krista Harrison, & Lauren Hunt

GeriPal

And yet, disenrollment from hospice, either due to patient/family revoking the benefit or stabilization of illness (extended prognosis) is remarkably high for people with dementia among some hospices. As a nurse case manager in hospice, half of my patients had dementia. And I had a blast playing Take the Money and Run! AlexSmithMD.

Family 106
article thumbnail

‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options

Physician's Weekly

But that’s when his family began fighting another adversary: their health insurer, which decided the treatment was “not medically necessary,” according to insurance paperwork. When the Tennant family was told histotripsy would cost $50,000 and insurance wouldn’t cover it, they appealed the denial four times.